D’Amato M. P074 | Innovative MRD detection and immune profiling in relapsed CLL treated with rituximab-venetoclax: insights from the “Dedalus” protocol: <a href="https://haematologica.org/search/search?query=M.+D’Amato">M. D’Amato</a>, <a href="https://haematologica.org/search/search?query=C.+Baratè">C. Baratè</a>, <a href="https://haematologica.org/search/search?query=C.+Bono">C. Bono</a>, <a href="https://haematologica.org/search/search?query=F.+Guerrini">F. Guerrini</a>, <a href="https://haematologica.org/search/search?query=G.+Tancredi">G. Tancredi</a>, <a href="https://haematologica.org/search/search?query=E.+Benedetti">E. Benedetti</a>, <a href="https://haematologica.org/search/search?query=S.+Galimberti">S. Galimberti</a> | <i>University of Pisa, Italy.</i>. haematol [Internet]. 2026Mar.3 [cited 2026Mar.4];111(s1). Available from: https://haematologica.org/article/view/haematol.2026.s1.138